The National Institute of Health Research at Ten Years

To mark its tenth anniversary, the Department of Health commissioned the PRiSM unit to consider the question: ‘What are the ways in which NIHR has benefited the health research landscape in the past ten years?’

The National Institute for Health Research (NIHR) funds and supports world-leading clinical and applied health and social care research, as well as research infrastructure in the NHS. Providing £1 billion of funding each year, NIHR aims to: drive the faster translation of new treatments, technologies and diagnostics to improve outcomes for health and care services; promote the wealth of the nation, including via inward investment from the health research community; pull basic science discoveries through into tangible benefits for patients and the public; and provide research evidence to support more effective and cost-effective NHS delivery.

Summary of Impact Synthesis

The report summarises the impacts and benefits of NIHR’s support for clinical, applied health and social care research and research infrastructure across 100 case studies, clustered across 10 themes of delivery, collaboration and achievement.

Looking across the breadth of these 10 themes and the depth of the benefits synthesised in the 100 case studies, we see evidence that, over the past 10 years, NIHR has transformed R&D in and for the NHS and the patients it serves. The examples in these case studies illustrate that NIHR is undertaking world-class research, as well as supporting, enabling and delivering research through its partners. Specifically, it shows that:

  • NIHR is delivering benefits to patients. NIHR is developing innovations that can be delivered throughout the health and social care system, such as more personalised and cost-effective dementia care, the first ever implant of a fully synthetic trachea, new treatments for breast cancer and dedicated partnerships to support research in rare disease areas.
  • NIHR is improving the health of the public nationally and internationally. NIHR-supported public health research is leading to reductions in alcohol-related harm, improving smoking prevention strategies and increasing vaccination coverage for H1N1 and childhood immunisation. Worldwide, more than 1 million people stand to benefit from NIHR-funded research into the off-label use of tranexamic acid to aid clotting during traumatic bleeding.
  • NIHR is making the nation’s healthcare system more effective, cost-effective and safer. NIHR-funded research into patient safety has informed the World Health Organization’s (WHO) Surgical Safety Checklist, which is significantly reducing post-operative complications. Other research is identifying cost-effective solutions that save money in areas ranging from physical therapy, to dementia, to diabetes.
  • NIHR helps put patients and the public at the heart of research. NIHR is a world leader in patient and public involvement, and there have been tangible improvements to how research is able to deliver patient benefit. INVOLVE, NIHR-funded national public involvement centre and advisory group, helps ensure that patients and the public are effectively involved at all stages of research studies, making them more acceptable and meaningful for research users of all ages.
  • NIHR supports a research infrastructure in the NHS. NIHR supports a national research infrastructure of world-class research centres, units and facilities, as well as the Clinical Research Network. Together these provide coverage across the health research system in England and enable and facilitate both research funded by NIHR itself and research funded through charities, industry, and other government funders. In 2014/15, from an initial investment of £227.8 million, NIHR research infrastructure leveraged £1.06 billion in research funding from NIHR’s public, charity and industry research funding partners.

Access the report (and summary version)

Related Content

Publications

People

Catriona Manville

Catriona Manville

Dr. Catriona Manville is a Research Leader in RAND Europe's Innovation, Health and Science team. She is currently seconded part-time to the NIHR, where she works on business intelligence.

More...
Adam Kamenetzky

Adam Kamenetzky

Adam Kamenetzky is a Research Fellow at the King's Policy Institute, King's College London. His expertise lies in developing practical and robust methods to help researchers convey the impact of their work, and engaging decision-makers and the wider public around its value.

More...
Jonathan Grant

Jonathan Grant

Jonathan Grant is Director of the King’s Policy Institute, King's College London, and Senior Honorary Research Fellow at RAND Europe. His main research interests are on health R&D policy, the use of research and evidence in policy making and population policy issues.

More...
Molly Morgan Jones

Molly Morgan Jones

Molly Morgan Jones is Associate Director of the Innovation, Health and Science team at RAND Europe. She specialises in the governance of innovation, focusing in particular on biomedical and health technologies, and the evaluation of research impact.

More...